Human Liver Model Market Growth (2022-2030) | Industry Share, Size, Trends and Global Forecast Report, Growth Plus Reports

Newark, New Castle, USA, March 14, 2023 (GLOBE NEWSWIRE) -- As per the report published by Growth Plus Reports the Global Human Liver Model Market was estimated at US$ 1.39 billion in 2021 and is expected to surpass a valuation of US$ 3.98 billion by 2030, progressing at a CAGR of 12.4% from 2022 to 2030. The report provides a detailed analysis of top winning strategies, drivers & opportunities, competitive scenario, wavering market trends, market size, statistics & estimations, and major investment pockets.

Download PDF Brochure of Human Liver Model Market Size - COVID-19 Impact and Global Analysis with Strategic Developments at: https://www.growthplusreports.com/inquiry/request-sample/human-liver-model-market/8196

Human Liver Model Market Scope

The liver is the largest gland in the human body, and in charge of vital tasks such as bile generation, detoxification, glucose synthesis, and protein synthesis. Live cells have a special feature that aids in the regeneration of lost liver tissue. It allows for a better understanding of liver illnesses and the complicated spatial linkages of the liver's internal structure. Advanced liver models are mini-organs or organoids designed to mimic human liver physiology, architecture, and functions. The development of these live models is a novel field of study that has the potential to replace animal models. The human liver model is used to assess the toxicity of novel medications on the liver.

Market Drivers

Rapidly increasing demand for early diagnosis of medication toxicity to prevent financial losses due to late-stage therapeutic failure is one of the crucial drivers in the human liver model market. Due to their enhanced efficiency, there is a continuously growing preference for human liver models over animal testing models. The animal testing model is a common approach for drug testing. However, due to limitations of animal testing, ethical concerns, and drug testing accuracy and efficiency constraints, demand for human liver models has bloomed. These factors are also responsible for the growth of the overall market. Increasing deployment of various initiatives to promote organoids, rising investments in liver organoids research, and expanded use of human liver models for revolutionary medicine procedures are some of the key variables driving market advancement. Growing penetration of key players in R&D activities, rising government initiatives to encourage liver models, and the upsurging need for early identification of pharmaceutical toxicity to avert therapeutic failure in the final stage are some of the significant forces driving the human liver models market. Furthermore, these models are anticipated to produce viable bioengineered liver tissue cells for patient transplantation in the next years. Other factors predicted to offer development prospects for leading market participants in the coming years include a greater emphasis on drug research efforts and an increased demand for organ transplantation.

The global human liver model market has been analyzed from four perspectives: Type, Application, End-users, and Region.

Excerpts from ‘By Type Segmentation’

The drug class in the global human liver model market has been segmented into:

• Liver Organoids
• Animal Models
• Liver-On-A-Chip
• 3D bioprinting
• 2D models

Liver-on-a-chip registered for the largest revenue share in 2021. Similarly, 3D bioprinting is estimated to illustrate lucrative growth during the forecast timeline from 2022 to 2030. 3D bioprinting is one of the major trending concepts among researchers due to its vast applications and benefits, especially in developing organoids for drug toxicity testing. Advanced 3D bioprinting technologies can develop in vitro liver tissue models in both static scaffolds and dynamic liver-on-chip formats. It also has an important role in human liver modeling as an in vitro liver tissue model that can replicate the key features of the liver and can serve as a viable platform for evaluating liver disorders and generating novel medications. Furthermore, the constraints of typical planar monolayer cell cultures and animal experiments for assessing drug candidate toxicity and effectiveness can be eradicated. Thus, such factors drive the demand for 3D bioprinting technology, bolstering the global human liver model market growth. 

Request for Customization – https://www.growthplusreports.com/inquiry/customization/human-liver-model-market/8196

Excerpts from ‘By Region Segmentation’

The global human liver model market has been segmented into:

• North America
• Europe
• Asia Pacific
• Rest of the World

Asia Pacific region is estimated to be the fastest progressing market in terms of revenue growth during the projected time. The growth of the human liver market in the Asia Pacific can be attributed to the growing focus on drug discovery by major economies in this region, namely, China, Japan, India, South Korea, and Australia. Additionally, the growing interest of prominent market players in Asia Pacific regions due to emerging economies and the healthcare system also contributes to the market growth in this region. Rapidly advancing healthcare infrastructure and enhancing healthcare expenditure further boosts the human liver model market in the Asia Pacific region.

Excerpts from ‘Competitive Landscape’

The prominent market players operating in the human liver model market are:

• CB Information Services Inc.
• Organovo Holding Inc.
• Mimetas BV
• InSphero
• BioIVT
• Cellink (Bico Group)
• Kerafast Inc.
• Thermo Fisher Scientific Inc.
• HìREL

Table of Content

1. INTRODUCTION
   1. Market Ecosystem 
   2. Timeline Under Consideration
      1. Historical Years – 2020
      2. Base Year – 2021
      3. Forecast Years – 2022 to 2030
   3. Currency Used in the Report
2. RESEARCH METHODOLOGY 
   1. Research Approach
   2. Data Collection Methodology
   3. Data Sources
      1. Secondary Sources 
      2. Primary Sources 
   4. Market Estimation Approach
      1. Bottom Up 
      2. Top Down 
   5. Market Forecasting Model
   6. Limitations and Assumptions       
3. PREMIUM INSIGHTS
   1. Current Market Trends (COVID-19 Perspective)
   2. Key Players & Competitive Positioning (2021)
4. MARKET DYNAMICS
   1. Drivers
   2. Restraints
   3. Opportunities
5. GLOBAL HUMAN LIVER MODEL MARKET- ANALYSIS & FORECAST, BY TYPE
   1. Liver Organoids
   2. Animal Models
   3. Liver-on-a-chip
   4. 3D Bioprinting
   5. 2D Models
6. GLOBAL HUMAN LIVER MODEL MARKET- ANALYSIS & FORECAST, BY APPLICATION
   1. Academics
   2. Drug Discovery
   3. Others
7. GLOBAL HUMAN LIVER MODEL MARKET- ANALYSIS & FORECAST, BY END-USER
   1. Research Institutes 
   2. Pharmaceutical Companies
   3. Others

TOC Continued….

Buy this Premium Research Report: https://www.growthplusreports.com/checkout-8196

VALUE PROPOSITIONS RELATED TO THE REPORT:

• Powered with Complimentary Analyst Hours and Expert Interviews with Each Report
• Comprehensive quantitative and qualitative insights at segment and sub-segment level
• Covid 19 impact trends and perspective
• Granular insights at global/regional/country level
• Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment
• Blanket coverage on competitive landscape
• Winning imperatives
• Exhaustive coverage on 'Strategic Developments' registered by leading players of the market

CUSTOMIZATION OPTIONS:

• Distributor Landscape Assessment
• Pricing Intelligence
• Customer Base Assessment
• Investment & Initiatives Analysis
• 'Business Profile' of Key Players

Schedule a call with our analyst: https://appoint.ly/s/salesZ3Jvd3RocGx1c3JlcG9ydHMuY29t/introduction

Visit our report store at - https://www.growthplusreports.com/report-store

Browse related reports:

Proton Pump Inhibitors Market by Drug Type (Omeprazole, Esomeprazol), Distribution Channel (Hospital Pharmacies, Retail Pharmacies) - Global Outlook & Forecast 2023-2031

Point of Care CT Imaging Systems Market by Product (Compact POC CT Scanners, Full-Sized POC CT Scanners), Application (Musculoskeletal, Neurology), End User (Hospitals, Clinics) – Global Outlook & Forecast 2023-2031

Oncologic Nanomedicine Market by Type (Nano Shells, Nano Tubes, Nano Particles), Constituents (Inorganic Nanoparticles, Organic Nanoparticles), Application (Diagnostics, Therapeutic Agents, Drug Delivery Agents) - Global Outlook & Forecast 2023-2031

Neuroprotective Agents Market by Drug Class (Anesthetics, Cholinesterase Inhibitors, NMDA Receptors Antagonists), Application (Alzheimer's Disease, Epilepsy), Route of Administration (Oral, Topical), Distribution Channel (Hospital Pharmacies, Retail Pharmacies) – Global Outlook & Forecast 2023-2031

Interventional Cardiology Devices Market by Type (Angioplasty Stents, Structural heart Devices) - Global Outlook and Forecast 2023-2031

About Us:

Growth Plus Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association).

Growth Plus portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success.

We were awarded by the prestigious CEO Magazine as "Most Innovative Healthcare Market Research Company in 2020.